UCB CEO to Chair Innovative Medicines Initiative Board

News   Mar 12, 2012

 
UCB CEO to Chair Innovative Medicines Initiative Board
 
 
 

RELATED ARTICLES

Metabolomic Profiling Identifies Taurine as New MS Therapeutic

News

New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies. The discovery also highlights the potential for a technique called “metabolomic profiling,” which can identify useful endogenous metabolites the body already makes in small quantities, such as taurine, for new applications in drug therapies.

READ MORE

Chemists Have Synthesized New Isoquinoline Derivatives

News

Chemists have synthesized new isoquinoline derivatives. Due to their biological activity, these compounds may be applicable in new drugs, from antispasmodics to bactericidal agents. In addition, in the future they may show effectiveness in the treatment of Alzheimer's disease.

READ MORE

Researchers Develop a Platform to Produce Brand-new Antibiotics

News

A team of scientists at the University of Bristol have generated a brand-new platform that will allow the production of desperately needed brand-new antibiotics.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE